|
gptkbp:instanceOf
|
gptkb:division
|
|
gptkbp:acquiredBy
|
gptkb:Clarus
|
|
gptkbp:acquisitionYear
|
2018
|
|
gptkbp:focusesOn
|
gptkb:biotechnology
pharmaceuticals
medical devices
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Blackstone Life Sciences
|
|
gptkbp:industry
|
life sciences
healthcare investment
|
|
gptkbp:investedIn
|
private equity
venture capital
|
|
gptkbp:keyPerson
|
gptkb:John_McArthur
gptkb:John_Evans
gptkb:Robert_Langer
gptkb:John_Simon
gptkb:Michael_Pellini
gptkb:David_Hirsch
gptkb:John_Maraganore
gptkb:David_Steinberg
gptkb:Aaron_Davis
gptkb:Mark_Fishman
gptkb:Jean-François_Formela
gptkb:James_Fordyce
gptkb:Jeffrey_Schwartz
gptkb:John_Schmid
gptkb:Jonathan_Montagu
gptkb:Kurt_Wheeler
gptkb:Michael_Bonney
gptkb:Nicholas_Galakatos
gptkb:Sam_Hall
gptkb:Stephen_Bloch
gptkb:Stephen_Knight
gptkb:Stephen_Squinto
|
|
gptkbp:location
|
gptkb:United_States
|
|
gptkbp:notableInvestment
|
gptkb:Medtronic
gptkb:Pfizer
gptkb:Alnylam_Pharmaceuticals
gptkb:Novartis
gptkb:Autolus_Therapeutics
|
|
gptkbp:notableSale
|
$2 billion investment in Alnylam Pharmaceuticals (2020)
|
|
gptkbp:parentOrganization
|
gptkb:Blackstone_Inc.
|
|
gptkbp:website
|
https://www.blackstone.com/our-businesses/life-sciences/
|
|
gptkbp:bfsParent
|
gptkb:The_Blackstone_Group
|
|
gptkbp:bfsLayer
|
5
|